Sex-Differences and Temporal Consistency in Stickleback Fish Boldness
Journal Article
King, A. J., Furtbauer, I., Mamuneas, D., James, C., & Manica, A. Sex-Differences and Temporal Consistency in Stickleback Fish Boldness. PLoS ONE, 8(12), e81116. https://doi.org/10.1371/journal.pone.0081116
Outputs (2485)
Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats
Journal Article
King, J. N., Jung, M., Maurer, M. P., Schmid, V. B., Seewald, W., & Lees, P. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats. American Journal of Veterinary Research, 74(3), 465-472
INSIGHTS INTO THE ROLE OF INFLAMMATION IN DYSTROGLYCANOPATHIES - ANALYSING THE EFFECT OF ALPHA DYSTROGLYCAN GLYCOSYLATION ON IMMUNE FUNCTION
Journal Article
Lacey, E., Gullen, E., Hopkinson, M., Palmer, D. B., & Brown, S. C. INSIGHTS INTO THE ROLE OF INFLAMMATION IN DYSTROGLYCANOPATHIES - ANALYSING THE EFFECT OF ALPHA DYSTROGLYCAN GLYCOSYLATION ON IMMUNE FUNCTION. Immunology, 140, 97-97
INITIAL ACTIVATION OF BETA-CATENIN SIGNALING IN OSTEOCYTES IS PROSTAGLANDIN DEPENDENT
Journal Article
Lara, N., Kamel, M., Javaheri, B., & Johnson, M. INITIAL ACTIVATION OF BETA-CATENIN SIGNALING IN OSTEOCYTES IS PROSTAGLANDIN DEPENDENT. Journal of Bone and Mineral Research, 28,
MECHANISMS OF ENDOTHELIAL PROTECTION MEDIATED BY N-3 PUFAS CARRIED IN CHYLOMICRON REMNANTS
Journal Article
Latham, S. H., Purcell, R., Botham, K. M., & Wheeler-Jones, C. P. D. MECHANISMS OF ENDOTHELIAL PROTECTION MEDIATED BY N-3 PUFAS CARRIED IN CHYLOMICRON REMNANTS. Cardiology, 126, 246-246
Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat
Journal Article
Lees, P. Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat. Journal of Veterinary Pharmacology and Therapeutics, 36(3), 209-221. https://doi.org/10.1111/jvp.12036
Bioequivalence in dogs of a meloxicam formulation administered as a transmucosal oral mist with an orally administered pioneer suspension product
Journal Article
Lees, P., Cheng, Z. R., Keefe, T. J., Weich, E., Bryd, J., Cedergren, R., & Cozzi, E. Bioequivalence in dogs of a meloxicam formulation administered as a transmucosal oral mist with an orally administered pioneer suspension product. Journal of Veterinary Pharmacology and Therapeutics, 36(1), 78-84. https://doi.org/10.1111/j.1365-2885.2012.01402.x
Veterinary pharmacology: history, current status and future prospects
Journal Article
Lees, P., Fink-Gremmels, J., & Toutain, P. L. Veterinary pharmacology: history, current status and future prospects. Journal of Veterinary Pharmacology and Therapeutics, 36(2), 105-115. https://doi.org/10.1111/jvp.12041
Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses
Journal Article
Lees, P., & Toutain, P. L. Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses. https://doi.org/10.1016/j.tvjl.2013.04.019
Phenylbutazone in horses and man: Properties relevant to safety of humans consuming horse meat containing phenylbutazone and its metabolites
Journal Article
Lees, P., & Toutain, P. L. Phenylbutazone in horses and man: Properties relevant to safety of humans consuming horse meat containing phenylbutazone and its metabolites. Equine Veterinary Education, 25(11), 545-549. https://doi.org/10.1111/eve.12112